Contact: Kerri Kelley; Last date for abstract submission: Not available; In-depth look at the practical challenges of manufacturing autologous & allogenic cell therapies at scale, cell processing, scalability, bioreactors, next-generation production technologies, automation, closed systems, supply chain & facility design.